Existing Class of Drugs May Improve Neurological Function in Patients with Rare, Aggressive Genetic Disorder
Published on

A JAK inhibitor helped patients with Aicardi-Goutières Syndrome meet important developmental milestones.
Published on
A JAK inhibitor helped patients with Aicardi-Goutières Syndrome meet important developmental milestones.
Published on
Some diseases affect only a small number of people, and yet CHOP’s commitment to researching and treating them is huge.
Published on
Elise has Alexander disease, a type of leukodystrophy. Watch the video to learn how the Leukodystrophy Center at CHOP is committed to helping kids like Elise.
Published on
Amy Waldman, MD, and a patient family talk about research and fundraising efforts underway that seek to identify better treatment options for Alexander disease.
Published on
The Leukodystrophy Center sees patients from all over the country and the world. Our services include a newborn diagnostic clinic and a comprehensive care clinic that provides state-of-the art care.
Published on
The Carr-Kefalases and Hammonds presented a check of $110,000 to CHOP’s Leukodystrophy Center.
Published on
Leukodystrophy Center of Excellence was established in 2015 to address the medically complex needs of children living with leukodystrophies.
Published on
Adeline Vanderver, MD, aims to take leukodystrophy gene discovery, therapies, support and advocacy to the next level.
Published on
The 2016 Philadelphia Auto Show’s Black Tie Tailgate broke records, with more than 4,800 people helping to raise over $550,000 for the Division of Neurology.
Published on
CHOP's Leukodystrophy Center brings together a multidisciplinary group of caregivers to provide cutting-edge, comprehensive diagnostic testing, clinical care, and the most advanced treatment to infants and children with inherited white matter disease.